CTRI/2019/03/018306CompletedPhase 4
A prospective randomised comparative study of metformin versus myoinositol plus d-chiroinositol combination therapy in polycystic ovarian syndrome
Dr Sukhmani Jaura0 sites50 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Women fulfilling 2 out of 3 criteria of Rotterdam criteria
- •Oligo menorrhea and/or Anovulation
- •Clinical and/or hormonal parameters of hyperandrogenism that may be associated with Hirsutism
- •Polycystic ovaries in ultrasound findings
Exclusion Criteria
- •Women with pre-existing endocrine disorder
- •History of Hypertension & Diabetes Mellitus
- •Women who received previous treatment with other drugs within last 6 months
Investigators
Similar Trials
Not yet recruiting
Phase 4
Comparing the benefits and safety of Metformin and Canthex® for treating dark skin patches in patients of Acanthosis NigricansCTRI/2024/08/071850Rutuja Angad Shinde
Completed
Phase 2
Comparison the effect of Metformin and Rosiglitazone, alone and in combination, to treat polycystic ovary syndrome.Polycystic ovarian syndrome.Polycystic ovarian syndromeIRCT201605257513N12Vice chancelor of research of Isfahan University of Medical Sciences44
Recruiting
Phase 4
Preventive management of headache due to migraine.CTRI/2017/07/009074Ratul Banerjee108
Recruiting
Phase 3
A comparative study on efficacy, safety and tolerability of topical tofacitinib vs topical tofacitinib combined with puvasol in the management of vitiligoCTRI/2023/12/060436Dr Rohini Rathod
Not yet recruiting
Phase 3
Comparing efficacy and safety Methotrexate VS oral Tofacitinib in management of palmoplantar psoriasis.CTRI/2024/07/070540KIRTI NITIN HAJARE